For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Bostongene Corporation

Calculating rank

USPTO Granted Patents = 36

EPO Patents = 13

Trademarks = 4

Forward Citations = 147

Loading Chart...

Loading Chart...

56 inventors (with patents filed for the assignee):

Alexander Bagaev (30 out of 30 patents)

Ravshan Ataullakhanov (24 out of 27 patents)

Feliks Frenkel (21 out of 21 patents)

4. Nikita Kotlov (15 out of 15 patents)

5. Olga Isaeva (6 out of 6 patents)

6. Viktor Svekolkin (4 out of 4 patents)

7. Aleksandr Zaitsev (3 out of 3 patents)

8. Maksim Chelushkin (3 out of 3 patents)

9. Ekaterina Nuzhdina (3 out of 3 patents)

10. Ekaterina Postovalova (3 out of 3 patents)

11. Maksym Artomov (3 out of 3 patents)

12. Alexander Bagaev (3 out of 3 patents)

13. Ilya Cheremushkin (2 out of 2 patents)

14. Vladimir Zyrin (2 out of 2 patents)

15. Daniiar Dyikanov (2 out of 2 patents)

Core Competencies:

Flow Cytometry

CAR-T Therapy

Tumor Microenvironment

Machine Learning

Gene Expression

Biomarker Scores

Immunoprofiling

Therapeutic Vaccines

Multiplexed Imaging

Statistical Models

Checkpoint Blockade

36 patents: Sort by Forward Citations

1. 12584844 - Flow cytometry immunoprofiling of peripheral blood (2026-03-24),

2. 12580049 - Tumor microenvironment-based methods for assessing CAR-T and other immunotherapies (2026-03-17),

3. 12462941 - Pan-cancer tumor microenvironment classification based on immune escape mechanisms and immune infiltration (2025-11-04),

4. 12254961 - Hierarchical machine learning techniques for identifying molecular categories from expression data (2025-03-18),

5. 12205675 - Techniques for bias correction in sequence data (2025-01-21),

6. 11984200 - Systems and methods for generating, visualizing and classifying molecular functional profiles (2024-05-14),

7. 11915422 - Techniques for determining tissue characteristics using multiplexed immunofluorescence imaging (2024-02-27),

8. 11904002 - Construction and methods of use of a therapeutic cancer vaccine library comprising fusion-specific vaccines (2024-02-20),

9. 11842797 - Systems and methods for predicting therapy efficacy from normalized biomarker scores (2023-12-12),

10. 11705220 - Systems and methods for identifying cancer treatments from normalized biomarker scores (2023-07-18),

11. 11587642 - Systems and methods for deconvolution of expression data (2023-02-21),

12. 11568959 - Tumor microenvironment-based methods for assessing CAR-T and other immunotherapies (2023-01-31),

13. 11482301 - Gene expression analysis techniques using gene rankings and statistical models for identifying biological sample characteristics (2022-10-25),

14. 11430545 - Systems and methods for generating, visualizing and classifying molecular functional profiles (2022-08-30),

15. 11373733 - Systems and methods for generating, visualizing and classifying molecular functional profiles (2022-06-28),

Company Overview

Bostongene Corporation, based in Waltham, MA, specializes in precision medicine through advanced genomic analysis. The company focuses on leveraging proprietary technologies to provide insights into cancer genomics, enabling personalized treatment strategies for patients. Bostongene's innovative platform integrates comprehensive genomic data with clinical information, aiming to enhance therapeutic decision-making and improve patient outcomes. Their commitment to transforming cancer care positions them at the forefront of the biotechnology landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

36 Patents

#45 in Waltham, MA

#562 in Massachusetts

#9,527 in US

#18,762 in the World

Waltham, MA, United States of America

Bostongene Corporation

Forward Citations = 147

56 inventors:

Alexander Bagaev (30 out of 30 patents)

Ravshan Ataullakhanov (24 out of 27 patents)

Feliks Frenkel (21 out of 21 patents)

4. Nikita Kotlov (15 out of 15 patents)

5. Olga Isaeva (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bostongene Corporation. Retrieved from https://idiyas.com/company/bostongene

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…